Spruce Biosciences (SPRB)
US Market

Spruce Biosciences Financial Statements


Spruce Biosciences Financial Overview

Spruce Biosciences's market cap is currently ―. The company's EPS TTM is $-1.887; its P/E ratio is -1.12; Spruce Biosciences is scheduled to report earnings on March 13, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Mar 22Dec 21Sep 21Jun 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ ―$ ―$ ―$ ―$ ―
EBIT$ -11.78M$ -11.68M$ -9.10M$ -11.36M$ -11.69M
EBITDA$ -11.77M$ -11.65M$ -9.08M$ -11.34M$ -11.68M
Net Income Common Stockholders$ -11.87M$ -11.76M$ -9.18M$ -11.45M$ -11.77M
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 72.16M$ 88.97M$ 91.35M$ 92.32M$ 93.30M
Total Assets$ 104.52M$ 114.99M$ 126.49M$ 135.09M$ 143.45M
Total Debt$ 3.91M$ 4.64M$ 5.53M$ 6.04M$ 6.95M
Net Debt$ -68.25M$ -84.33M$ -85.82M$ -86.28M$ -86.35M
Total Liabilities$ 15.39M$ 14.74M$ 15.12M$ 15.37M$ 13.34M
Stockholders Equity$ 89.12M$ 100.24M$ 111.37M$ 119.72M$ 130.11M
Cash Flow
Free Cash Flow$ -9.55M$ -11.83M$ -9.80M$ -7.66M$ -9.70M
Operating Cash Flow$ -9.54M$ -11.83M$ -9.80M$ -7.60M$ -9.69M
Investing Cash Flow$ 33.51M$ -7.49M$ -5.98M$ -12.34M$ -60.83M
Financing Cash Flow$ -99.00K$ -88.00K$ 167.00K$ 17.00K$ 176.00K
Currency in USD

Spruce Biosciences Earnings and Revenue History

Spruce Biosciences Debt to Assets

Spruce Biosciences Cash Flow

Spruce Biosciences Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis